Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1864) 1864
Publication (236) 236
Book Chapter (40) 40
Book Review (34) 34
Book / eBook (10) 10
Conference Proceeding (3) 3
Dissertation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1309) 1309
index medicus (1058) 1058
oncology (760) 760
cancer (570) 570
male (551) 551
female (550) 550
middle aged (431) 431
metastasis (404) 404
aged (391) 391
tumors (333) 333
adult (322) 322
chemotherapy (319) 319
metastatic colorectal-cancer (264) 264
animals (243) 243
medicine & public health (238) 238
surgery (232) 232
prognosis (226) 226
care and treatment (219) 219
pathology (219) 219
metastatic breast-cancer (212) 212
neuroendocrine tumors (209) 209
treatment outcome (203) 203
diagnosis (192) 192
survival (189) 189
research (188) 188
antineoplastic agents - therapeutic use (173) 173
immunohistochemistry (173) 173
aged, 80 and over (169) 169
neoplasms - drug therapy (163) 163
health aspects (158) 158
carcinoma (148) 148
radiology, nuclear medicine & medical imaging (144) 144
management (138) 138
pharmacology & pharmacy (137) 137
metastases (136) 136
analysis (135) 135
retrospective studies (133) 133
cell lung-cancer (129) 129
neoplasm metastasis (129) 129
therapy (128) 128
liver neoplasms - secondary (127) 127
endocrinology & metabolism (121) 121
article (120) 120
metastatic pheochromocytoma (119) 119
phase-ii trial (119) 119
metastatic (118) 118
breast-cancer (113) 113
renal-cell carcinoma (113) 113
antineoplastic combined chemotherapy protocols - therapeutic use (108) 108
endothelial growth-factor (106) 106
expression (105) 105
metastatic melanoma (104) 104
review (104) 104
melanoma (103) 103
patients (103) 103
positron-emission-tomography (103) 103
prostate cancer (103) 103
cell biology (101) 101
paraganglioma (98) 98
breast cancer (97) 97
metastatic neuroendocrine tumors (96) 96
gastroenterology & hepatology (94) 94
hematology, oncology and palliative medicine (94) 94
liver (91) 91
clinical trials (89) 89
angiogenesis (86) 86
development and progression (86) 86
disease-free survival (86) 86
adenocarcinoma (84) 84
mutation (84) 84
survival rate (84) 84
cancer therapies (83) 83
liver metastases (82) 82
phase-ii (81) 81
cancer research (79) 79
double-blind (78) 78
risk factors (78) 78
metastatic disease (77) 77
colorectal cancer (76) 76
medicine (76) 76
mice (75) 75
neoplasms (75) 75
phase-iii trial (75) 75
medical prognosis (74) 74
pheochromocytoma (74) 74
immunotherapy (73) 73
lung-cancer (73) 73
neoplasms - pathology (73) 73
survival analysis (73) 73
metastatic carcinoma (71) 71
disease progression (70) 70
usage (70) 70
drug therapy (69) 69
diagnosis, differential (68) 68
medical research (67) 67
pancreatic neoplasms - pathology (67) 67
prognostic-factors (67) 67
neoplasm staging (66) 66
solid tumors (66) 66
adolescent (65) 65
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1866) 1866
French (17) 17
German (12) 12
Japanese (6) 6
Korean (6) 6
Spanish (2) 2
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Neuroendocrine Tumors
by Basuroy, Ron and Srirajaskanthan, Raj and Ramage, John K
Gastroenterology Clinics of North America, ISSN 0889-8553, 09/2016, Volume 45, Issue 3, pp. 487 - 507
Neuroendocrine tumors are increasingly diagnosed, either incidentally as part of screening processes, or for symptoms, which have commonly been mistaken for... 
Therapy | Tumor | Carcinoid | Diagnostics | Multimodal | Neuroendocrine | METASTATIC CARCINOID-TUMORS | SOMATOSTATIN ANALOGS | PROGNOSTIC-FACTORS | LONG-TERM OUTCOMES | GASTROINTESTINAL-TRACT | HEPATIC ARTERIAL CHEMOEMBOLIZATION | CHROMOGRANIN-A | LIVER METASTASES | PHASE-II TRIAL | RECEPTOR RADIONUCLIDE THERAPY | GASTROENTEROLOGY & HEPATOLOGY | Pancreatic Neoplasms - metabolism | Pancreatic Neoplasms - diagnosis | Humans | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Liver Neoplasms - therapy | Neuroendocrine Tumors - diagnosis | Embolization, Therapeutic | Organometallic Compounds | Gastrointestinal Neoplasms - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Chromogranin A - metabolism | Receptors, Somatostatin - metabolism | Liver Neoplasms - secondary | Radiopharmaceuticals | Gastrointestinal Neoplasms - metabolism | Neuroendocrine Tumors - metabolism | Pancreatic Neoplasms - pathology | Hepatic Artery | Hydroxyindoleacetic Acid - metabolism | Gastrointestinal Neoplasms - diagnosis | Gastrointestinal Neoplasms - therapy | Octreotide - therapeutic use | Malignant Carcinoid Syndrome - therapy | Positron Emission Tomography Computed Tomography | Magnetic Resonance Imaging | Metastasectomy | Digestive System Surgical Procedures | Neuroendocrine Tumors - secondary | Serotonin - metabolism | Gallium Radioisotopes | Fluorodeoxyglucose F18 | Neuroendocrine Tumors - therapy | Neoplasm Staging | Pancreatic Neoplasms - therapy
Journal Article
Details down arrow
2. Full Text The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: Well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum
by Boudreaux, J. Philip and Klimstra, David S and Hassan, Manal M and Woltering, Eugene A and Jensen, Robert T and Goldsmith, Stanley J and Nutting, Charles and Bushnell, David L and Caplin, Martyn E and Yao, James C and North American Neuroendocrine Tumor Society (NANETS)
Pancreas, ISSN 0885-3177, 08/2010, Volume 39, Issue 6, pp. 753 - 766
Well-differentiated neuroendocrine tumors (NETs) of the jejunum, ileum, and appendix are also collectively known as midgut carcinoids. Similar to NETs in... 
ileum | jejunum | cecum | appendix | neuroendocrine tumors | METASTATIC CARCINOID-TUMORS | RISK-FACTORS | ENDOCRINE TUMORS | PHASE-II | CHROMOGRANIN-A | SMALL-INTESTINAL CANCER | ANESTHETIC MANAGEMENT | 5-HYDROXYINDOLEACETIC ACID | SOMATOSTATIN RECEPTOR SCINTIGRAPHY | RECOMBINANT INTERFERON-ALPHA | GASTROENTEROLOGY & HEPATOLOGY | Cecum - pathology | Ileum - pathology | Jejunum - pathology | Appendix - pathology | Humans | Neuroendocrine Tumors - diagnosis | Intestinal Neoplasms - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The north american neuroendocrine tumor society consensus guideline for the diagnosis and management of neuroendocrine tumors: Pheochromocytoma, paraganglioma, and medullary thyroid cancer
by Chen, Herbert and Sippel, Rebecca S and O'Dorisio, M. Sue and Vinik, Aaron I and Lloyd, Ricardo V and Pacak, Karel and North American Neuroendocrine Tumor Society (NANETS)
Pancreas, ISSN 0885-3177, 08/2010, Volume 39, Issue 6, pp. 775 - 783
Pheochromocytomas, intra-adrenal paraganglioma, and extra-adrenal sympathetic and parasympathetic paragangliomas are neuroendocrine tumors derived from adrenal... 
medullary thyroid cancer | pheochromocytoma | neuroendocrine tumors | paraganglioma | LYMPH-NODE DISSECTION | MALIGNANT PHEOCHROMOCYTOMAS | METASTATIC PHEOCHROMOCYTOMA | GENOTYPE-PHENOTYPE CORRELATIONS | I-123 METAIODOBENZYLGUANIDINE | ENDOCRINE NEOPLASIA TYPE-2 | BIOCHEMICAL-DIAGNOSIS | POSITRON-EMISSION-TOMOGRAPHY | FUNCTIONAL PARAGANGLIOMA | LOCALIZING PHEOCHROMOCYTOMAS | GASTROENTEROLOGY & HEPATOLOGY | Thyroid Neoplasms - therapy | Thyroid Neoplasms - diagnosis | Paraganglioma - therapy | Pheochromocytoma - diagnosis | Humans | Neuroendocrine Tumors - diagnosis | Neuroendocrine Tumors - therapy | Paraganglioma - diagnosis | Pheochromocytoma - therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Biology and evolution of poorly differentiated neuroendocrine tumors
by Rickman, David S and Beltran, Himisha and Demichelis, Francesca and Rubin, Mark A
Nature Medicine, ISSN 1078-8956, 06/2017, Volume 23, Issue 6, pp. 664 - 673
Neuroendocrine (NE) cancers are a diverse group of neoplasms typically diagnosed and treated on the basis of their site of origin. This Perspective focuses on... 
MOLECULAR CHARACTERIZATION | MEDICINE, RESEARCH & EXPERIMENTAL | PANCREATIC ENDOCRINE NEOPLASMS | TRANSGENIC MOUSE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTIANDROGEN RESISTANCE | CONDITIONAL MOUSE MODEL | AURORA KINASE | METASTATIC PROSTATE-CANCER | T-ANTIGEN | CELL BIOLOGY | CELL LUNG-CANCER | N-MYC | Lung Neoplasms - drug therapy | Colonic Neoplasms - genetics | Carcinoma, Small Cell - genetics | Colonic Neoplasms - drug therapy | Epigenesis, Genetic | Humans | Male | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Tumor Suppressor Protein p53 - genetics | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Prostatic Neoplasms - genetics | Urinary Bladder Neoplasms - genetics | Female | Cell Differentiation | Retinoblastoma Binding Proteins - genetics | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Triazoles - therapeutic use | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Neuroendocrine - drug therapy | Carcinoma, Small Cell - drug therapy | Carcinogenesis - genetics | Head and Neck Neoplasms - drug therapy | Carcinoma, Neuroendocrine - genetics | Uterine Cervical Neoplasms - drug therapy | Urinary Bladder Neoplasms - drug therapy | Uterine Cervical Neoplasms - genetics | Disease Progression | Azepines - therapeutic use | Neuroendocrine Tumors - genetics | Proto-Oncogene Proteins c-met - genetics | Cell Lineage | Cell Plasticity - genetics | Esophageal Neoplasms - genetics | Pyrimidines - therapeutic use | Neuroendocrine Tumors - drug therapy | Head and Neck Neoplasms - genetics | Proto-Oncogene Proteins c-myc - genetics | Ubiquitin-Protein Ligases - genetics | Benzodiazepines - therapeutic use | Esophageal Neoplasms - drug therapy | Proteins | Research | Health aspects | Carcinogenesis | Gastrin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Liver transplantation for neuroendocrine tumors in Europe - Results and trends in patient selection: A 213-case European liver transplant registry study
by Le Treut, Yves Patrice and Grégoire, Emilie and Klempnauer, Jürgen and Belghiti, Jacques and Jouve, Elisabeth and Lerut, Jan and Castaing, Denis and Soubrane, Olivier and Boillot, Olivier and Mantion, Georges and Homayounfar, Kia and Bustamante, Manuel and Azoulay, Daniel and Wolf, Philippe and Krawczyk, Marek and Pascher, Andreas and Suc, Bertrand and Chiche, Laurence and De Urbina, Jorge Ortiz and Mejzlik, Vladimir and Pascual, Manuel and Lodge, J. Peter A and Gruttadauria, Salvatore and Paye, François and Pruvot, François-René and Thorban, Stefan and Foss, Aksel and Adam, René and ELITA and For ELITA
Annals of Surgery, ISSN 0003-4932, 05/2013, Volume 257, Issue 5, pp. 807 - 815
Objective: The purpose of this study was to assess outcomes and indications in a large cohort of patients who underwent liver transplantation (LT) for liver... 
multivariate analysis | liver transplantation | neuroendocrine tumors | prognostic study | SURVIVAL | SURGERY | MANAGEMENT | PROGNOSTIC-FACTORS | EXPERIENCE | METASTATIC ENDOCRINE TUMORS | Multivariate Analysis | Liver Transplantation | Prognosis | Follow-Up Studies | Europe | Humans | Middle Aged | Liver Neoplasms - surgery | Male | Treatment Outcome | Liver Neoplasms - mortality | Patient Selection | Young Adult | Neuroendocrine Tumors - secondary | Adolescent | Neuroendocrine Tumors - mortality | Survival Analysis | Adult | Female | Neuroendocrine Tumors - surgery | Registries | Aged | Retrospective Studies | Liver Neoplasms - secondary
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting
by Matthew H. Kulke and Lillian L. Siu and Joel E. Tepper and George Fisher and Deborah Jaffe and Daniel G. Haller and Lee M. Ellis and Jacqueline K. Benedetti and Emily K. Bergsland and Timothy J. Hobday and Eric Van Cutsem and James Pingpank and Kjell Oberg and Steven J. Cohen and Mitchell C. Posner and James C. Yao and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Institutionen för medicinska vetenskaper and Medicin
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 7, pp. 934 - 943
Neuroendocrine tumors (NETs) arise from a variety of anatomic sites and share the capacity for production of hormones and vasoactive peptides. Because of their... 
METASTATIC CARCINOID-TUMORS | GRADING SYSTEM | NUCLEOTIDE POLYMORPHISM ANALYSIS | PANCREATIC ENDOCRINE TUMORS | SOMATOSTATIN ANALOG | ALLELIC ALTERATIONS | PROGNOSTIC-FACTORS | PROGRESSION-FREE SURVIVAL | PHASE-II | OCTREOTIDE LAR | ONCOLOGY | Neuroendocrine Tumors - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | United States | Humans | National Cancer Institute (U.S.) | Male | Treatment Outcome | Forecasting | Randomized Controlled Trials as Topic | Clinical Trials, Phase III as Topic | Neuroendocrine Tumors - mortality | Survival Analysis | Neuroendocrine Tumors - drug therapy | Female | Practice Guidelines as Topic | Endo2 | Rare | Special | Bios4 | Bios3 | Endo7 | Endo5 | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Current Chemotherapy Use in Neuroendocrine Tumors
by Chan, David L and Singh, Simron
Endocrinology and Metabolism Clinics of North America, ISSN 0889-8529, 09/2018, Volume 47, Issue 3, pp. 603 - 614
The role of chemotherapy in neuroendocrine tumors (NETs) has evolved with the development of other effective systemic therapies. At the same time, the evolving... 
Chemotherapy | Metastatic | Neuroendocrine tumors | STREPTOZOCIN PLUS FLUOROURACIL | ENETS CONSENSUS GUIDELINES | DOXORUBICIN | ADVANCED CARCINOID-TUMORS | TEMOZOLOMIDE | CELL LUNG-CANCER | PHASE-III TRIAL | CAPECITABINE | HIGH-GRADE | CISPLATIN | ENDOCRINOLOGY & METABOLISM | Neuroendocrine Tumors - drug therapy | Neuroendocrine Tumors - surgery | Antineoplastic Agents - therapeutic use | Chemotherapy, Adjuvant | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans
Journal Article
Details down arrow
8. Full Text Ghrelin in neuroendocrine tumors
by Vu, John P and Wang, Hank S and Germano, Patrizia M and Pisegna, Joseph R
Peptides, ISSN 0196-9781, 11/2011, Volume 32, Issue 11, pp. 2340 - 2347
► We examine ghrelin expression in neuroendocrine tumors (NETs). ► We review ghrelin's expression in NETs patients with carcinoids, type A chronic atrophic... 
Cancer cachexia | Orexigenic | Endogenous | Ghrelin | Metastatic neuroendocrine tumors | SOMATOSTATIN ANALOGS | BIOCHEMISTRY & MOLECULAR BIOLOGY | GASTROINTESTINAL-TRACT | ENDOCRINE TUMORS | CHROMOGRANIN-A | DES-ACYL GHRELIN | AGOUTI-RELATED PROTEIN | GROWTH-HORMONE SECRETAGOGUE | MESSENGER-RNA | CARCINOID-TUMORS | PHARMACOLOGY & PHARMACY | HELICOBACTER-PYLORI | Immunohistochemistry | Body Weight | Central Nervous System - metabolism | Humans | Gene Expression Regulation, Neoplastic | Male | Carcinoid Tumor - blood | Gastric Mucosa - metabolism | Gastritis, Atrophic - blood | Ghrelin - biosynthesis | Receptors, Ghrelin - genetics | Liver Neoplasms - blood | Gastrointestinal Neoplasms - pathology | In Situ Hybridization | Gastrointestinal Neoplasms - blood | Polymerase Chain Reaction | Receptors, Ghrelin - metabolism | Liver Neoplasms - secondary | Gastritis, Atrophic - pathology | Acylation | Ghrelin - genetics | Carcinoid Tumor - pathology | Ghrelin - metabolism | Multiple Endocrine Neoplasia Type 1 - pathology | Multiple Endocrine Neoplasia Type 1 - blood | Appetite Regulation - physiology | Chronic Disease | Peptides | Liver cancer | Metastasis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges
by Castaño, J P and Sundin, A and Maecke, H R and Villabona, C and Vazquez-Albertino, R and Navarro, E and Öberg, K and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Enheten för radiologi and Onkologisk endokrinologi and Institutionen för radiologi, onkologi och strålningsvetenskap and Uppsala universitet and Institutionen för medicinska vetenskaper
Cancer and Metastasis Reviews, ISSN 0167-7659, 3/2014, Volume 33, Issue 1, pp. 353 - 359
This paper summarizes the current understanding of the biology of somatostatin receptor (sst), role of immunotherapy in neuroendocrine tumor (NET), new agents... 
RECIST, SWOG, WHO criteria | Somatostatin receptor | Splicing | GIPR | Oncology | Interferon (IFN) | Biomedicine general | sst5TMD4 | Biomedicine | Incretin receptor (GLP-1R | Cancer Research | Somatostatin | Functional NET imaging | PET | Peptide receptor radionucleotide therapy (PRRT) | Incretin receptor (GLP-1R; GIPR) | SURVIVAL | SOMATOSTATIN ANALOGS | RESPONSE CRITERIA | INTERFERON-ALPHA | PITUITARY-TUMORS | ONCOLOGY | MIDGUT CARCINOID-TUMORS | METASTATIC BREAST-CANCER | GASTROENTEROPANCREATIC TUMORS | LEUKOCYTE INTERFERON | RECEPTOR SUBTYPE 5 | Immunotherapy - methods | Reproducibility of Results | Somatostatin - analogs & derivatives | Neuroendocrine Tumors - metabolism | Humans | Treatment Outcome | Neuroendocrine Tumors - diagnosis | Gastrointestinal Neoplasms - diagnosis | Gastrointestinal Neoplasms - therapy | Diagnostic Imaging - methods | Sensitivity and Specificity | Neuroendocrine Tumors - therapy | Receptors, Somatostatin - metabolism | Somatostatin - therapeutic use | Gastrointestinal Neoplasms - metabolism | Peptides | Immunotherapy | Diagnosis | Biological response modifiers | Health aspects | Cells | Tumors | WHO criteria | RECIST | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine | SWOG | Cancer and Oncology | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Management of Pancreatic Neuroendocrine Tumors
by Dickson, Paxton V and Behrman, Stephen W
Surgical Clinics of North America, ISSN 0039-6109, 06/2013, Volume 93, Issue 3, pp. 675 - 691
Pancreatic neuroendocrine tumors account for 1% to 2% of pancreatic neoplasms and may occur sporadically or as part of a hereditary syndrome. Patients may... 
Pancreatic neuroendocrine tumors | Chemotherapy | Metastatic neuroendocrine tumors | Targeted therapy | Surgery | LONG-TERM SURVIVAL | HEPATIC ARTERIAL CHEMOEMBOLIZATION | ENDOCRINE TUMORS | PHASE-II | CHROMOGRANIN-A | SURGICAL-TREATMENT | LIVER METASTASES | CONSENSUS GUIDELINES | LOW-GRADE | RADIOFREQUENCY ABLATION | Neuroendocrine Tumors - pathology | Liver Transplantation | Pancreatic Neoplasms - diagnosis | Humans | Pancreatic Neoplasms - pathology | Pancreatectomy | Ablation Techniques | Combined Modality Therapy | Liver Neoplasms - therapy | Neuroendocrine Tumors - diagnosis | Embolization, Therapeutic | Pancreaticoduodenectomy | Hepatectomy | Neuroendocrine Tumors - secondary | Neuroendocrine Tumors - therapy | Liver Neoplasms - secondary | Neoplasm Staging | Pancreatic Neoplasms - therapy
Journal Article
Details down arrow
11. Full Text Clinical features of pancreatic neuroendocrine tumors
by Grozinsky‐Glasberg, Simona and Mazeh, Haggi and Gross, David J
Journal of Hepato‐Biliary‐Pancreatic Sciences, ISSN 1868-6974, 08/2015, Volume 22, Issue 8, pp. 578 - 585
Pancreatic neuroendocrine tumors (PNETs), also known as islet cell tumors, are rare neoplasms that arise in the endocrine tissues of the pancreas. Most of... 
Pancreatic neuroendocrine tumors | Metastatic | Functioning | SURGERY | DIAGNOSIS | WATERY DIARRHEA | MANAGEMENT | ISLET CELL TUMOR | ZOLLINGER-ELLISON-SYNDROME | ENDOCRINE NEOPLASIA TYPE-1 | SURGICAL-TREATMENT | GLUCAGONOMA SYNDROME | HYPOGLYCEMIA | EXPERIENCE | GASTROENTEROLOGY & HEPATOLOGY | Neuroendocrine Tumors | Adenoma, Islet Cell | Proteoglycans | Humans | Zollinger-Ellison Syndrome | Vipoma | Pancreatic Neoplasms | Somatostatinoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Liver Transplantation for Neuroendocrine Tumors: What Have We Learned?
by Lim, Chetana and Lahat, Eylon and Osseis, Michael and Sotirov, Dobromir and Salloum, Chady and Azoulay, Daniel
Seminars in Liver Disease, ISSN 0272-8087, 11/2018, Volume 38, Issue 4, pp. 351 - 356
Abstract Neuroendocrine tumors are slow-growing tumors and associated with prolonged overall survival even in the presence of untreated liver metastases. The... 
Review Article | liver metastases | liver transplantation | neuroendocrine tumors | SURVIVAL | PROGNOSTIC-FACTORS | RESECTION | DEBULKING | OUTCOMES | GASTROENTEROLOGY & HEPATOLOGY | METASTATIC ENDOCRINE TUMORS | Liver Transplantation | Outcome Assessment (Health Care) | Humans | Neoplasm Recurrence, Local | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Palliative Care | Carcinoma, Hepatocellular - secondary | Liver Neoplasms - mortality | Transplant Recipients | Hepatectomy | Disease-Free Survival | Quality of Life | Neuroendocrine Tumors - surgery | Liver Neoplasms - secondary
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours
by Meyer, Tim and Qian, Wendi and Caplin, Martyn E and Armstrong, Graham and Lao-Sirieix, Si-Houy and Hardy, Richard and Valle, Juan W and Talbot, Denis C and Cunningham, David and Reed, Nick and Shaw, Ashley and Navalkissoor, Shaunak and Luong, Tu-Vinh and Corrie, Pippa G
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 50, Issue 5, pp. 902 - 911
Abstract Background Cytotoxic chemotherapy is widely used for advanced, unresectable pancreatic and other gastrointestinal foregut neuroendocrine tumours... 
Hematology, Oncology and Palliative Medicine | Chemotherapy | Neuroendocrine tumour | Randomised clinical trial | Capecitabine | Streptozocin | Phase II | Cisplatin | ISLET-CELL CARCINOMA | PHASE-III | DOXORUBICIN | OXALIPLATIN | METASTATIC COLORECTAL-CANCER | TEMOZOLOMIDE | 5-FLUOROURACIL | ONCOLOGY | PANCREATIC ENDOCRINE CARCINOMAS | PLUS FLUOROURACIL | Gastrointestinal Neoplasms - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Fatigue - chemically induced | Diarrhea - chemically induced | Cisplatin - administration & dosage | Pancreatic Neoplasms - drug therapy | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Aged, 80 and over | Adult | Deoxycytidine - adverse effects | Female | Surveys and Questionnaires | Streptozocin - adverse effects | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Anemia - chemically induced | Treatment Outcome | Streptozocin - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Neuroendocrine Tumors - drug therapy | Quality of Life | Aged | Deoxycytidine - analogs & derivatives | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Small intestinal neuroendocrine tumours and fibrosis: An entangled conundrum
by Blažević, Anela and Hofland, Johannes and Hofland, Leo J and Feelders, Richard A and De Herder, Wouter W
Endocrine-Related Cancer, ISSN 1351-0088, 03/2018, Volume 25, Issue 3, pp. R115 - R130
Small intestinal neuroendocrine tumours (SI-NETs) are neoplasms characterized by their ability to secrete biogenic amines and peptides. These cause distinct... 
Neuroendocrine tumour | Targeted therapy | Growth factors | Tumour microenvironment | Fibrosis | METASTATIC CARCINOID-TUMOR | targeted therapy | neuroendocrine tumour | SIGNALING PATHWAYS | growth factors | STELLATE CELLS | FACTOR-ALPHA | TAMOXIFEN THERAPY | EPITHELIAL-MESENCHYMAL TRANSITION | GROWTH-FACTOR RECEPTOR | SEROTONIN SYNTHESIS | ONCOLOGY | ENDOCRINOLOGY & METABOLISM | CONSENSUS GUIDELINES UPDATE | fibrosis | tumour microenvironment | SUBSTANCE-P | Mesentery - metabolism | Neuroendocrine Tumors - pathology | Intestine, Small - pathology | Neuroendocrine Tumors - metabolism | Humans | Intestinal Neoplasms - metabolism | Tumor Microenvironment | Intestinal Neoplasms - pathology | Animals | Mesentery - pathology | Neuroendocrine Tumors - drug therapy | Intestine, Small - metabolism | Intestinal Neoplasms - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights